Occlutech leak device for mitral or aortic paravalvular leaks
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This registry tracks the safety and effectiveness of a device designed to close leaks around heart valves (mitral or aortic). It may be an option for people who have significant symptoms like heart failure or anemia from these leaks and are not good candidates for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a leak around a mitral or aortic heart valve that causes serious symptoms like severe heart failure or low red blood cells that need transfusions.
- A surgeon has determined that traditional open-heart surgery is too risky for you, or you are being offered this device as a less invasive option.
- You are willing to attend follow-up visits and can provide written consent.
- You are not ineligible for the device due to factors like active infection, allergies to nickel or titanium, need for blood thinners you cannot take, or recent heart attack or surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a study that collects information from people who are having a minimally invasive procedure to close a leak around a heart valve replacement device. It may help doctors better understand how well this procedure works and what outcomes to expect.
This study checks how well and how safely the Occlutech PDA Occluder works over time to close a patent ductus arteriosus (PDA). You may be considered if your PDA can be treated with this non-surgical device and you can return for follow-up visits.
This study checks whether an innovative device can safely replace a damaged mitral valve in people who are higher risk for open-heart surgery. It looks at how well the procedure and follow-up work for improving mitral leakage symptoms.
This follow-up study monitors how well and how safely the Occlutech mVSD device works to close certain muscular heart “holes” (ventricular septal defects). You may join if you already had the device placed and can return for scheduled checkups to help doctors learn long-term outcomes.
This trial tests a new device for people whose mitral valve leaks badly (grade 3+ or 4+) and who are not candidates for surgery. The device aims to fix the leak through a less invasive approach, and the study checks if it's safe and works well in daily life.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
Hear when a new Paravalvular Leak trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.